Filter posts

The Eyes Have It According to Recent VC Funding Patterns

A recent Wall Street Journal analysis of venture capital investment trends since 1999 reveals which …

BIO Announces Cleantech Investor Speakers for 2014 World Congress

Emerging companies to showcase their ground-breaking achievements  A selective group of CEOs and COOs from …

Driving Innovation in Breast Cancer: Startup Challenge

The Avon Foundation (AF), National Institutes of Health National Cancer Institute (NCI) and Center for …

Venture Capital Trends

With industry data and numbers, results are always a mixed bag, says David Thomas, BIO’s …

BIO-Europe Spring Opening Remarks

BIO’s own David Thomas, Director of Industry Research, delivered opening remarks at the BIO-Europe Spring …

Biotech Hall of Fame: Interview with Biotech’s First Investment Banker

Earlier this week, I had the opportunity to discuss biotech’s storied history with Fred Frank, …

Big Ventures

It is rare to see triple digit millions in private financing rounds, but it does …

It Takes a Village: The New Pharma-VC Model for Biotech Investing

High-profile funding collaborations between pharmaceutical companies and traditional venture capital funds have made headlines in …

BIO Europe Spring 2012 - Opening Remarks

For Monday’s Opening Remarks at BIO Europe Spring 2012, I covered the following topics: Public …

Venture Capital increases in 2011, but...

The National Venture Capital Association (NVCA) has released their 4Q 2011 numbers for biotech venture …